FDA Inspection
LifeStream Blood BankLifeStream Blood Bank – FDA Inspection, Aug 23, 2018
Record Details
This FDA Inspection record concerns LifeStream Blood Bank, with an inspection on August 23, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · cf0c301e-0fef-4959-ba64-db72ef6168f8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1063852
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeStream Blood Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 30, 2025 | NAI | Center for Biologics Evaluation and Research | |
| January 13, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 10, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 14, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 29, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeStream Blood Bank
- FDA Inspection 1252910 - 2025-05-30
- FDA Inspection 1195894 - 2023-01-13
- FDA Inspection 949717 - 2015-11-10
- FDA Inspection 833540 - 2013-05-14
- FDA Inspection 747541 - 2011-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.